Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Feds Greenlight Expanded Naloxone Availability

    The FDA has approved the nasal spray version of the opioid overdose reversal agent for over-the-counter sales.

  • Health Systems Look to Duplicate California Substance Use Disorder Treatment Model

    Administrators in several states want to leverage their EDs as a critical point of access to identify and treat substance use disorder.

  • Why Navigators Are Essential to CA Bridge

    While not all participating EDs in California have a Bridge clinic on their campus, the essence of the model is to make it easy for patients to receive the care they need. To do this, each ED should designate a champion to drive the program and a navigator to facilitate treatment access.

  • ET3 Pilot Hailed as Big Step Toward Fully Leveraging EMS

    In January 2021, the Centers for Medicare & Medicaid Services launched a five-year pilot program called Emergency Triage, Treat, and Transport (ET3), an approach that enables participating EMS programs to connect some patients with lower-acuity problems to emergency providers via telemedicine at the scene. Most participants are excited about leveraging the approach to accelerate needed care to patients, decompress EDs, and maximize the skills of the EMS workforce.

  • Tennessee Develops EMS Response Program for Low-Acuity Medicaid Patients

    The program, modeled after ET3, once implemented statewide, is estimated to reduce unnecessary visits to the ED, ease crowding of emergency medical services, and generate more than $8 million annually in Tennessee Medicaid program savings.

  • Just One Malpractice Payout Means Far Higher Risk for Future Claims

    Of 841,961 physicians with zero paid claims in the 2009-2013 period, only 3.3% were the subject of one or more claims in the next five years (2018-2023). Of 34,512 physicians with one paid claim in the prior period, 12% were the subject of one or more claims in the next five years. Of 4,189 physicians with two paid claims in the prior period, 22.4% were the subject of one or more claims in the next five years. Of 1,214 physicians with three paid claims in the prior period, 37% were the subject of one or more claims in the next five years.

  • EDs Can Mitigate Malpractice Perils of High-Risk Medications

    Many emergency providers are hesitant to deprescribe medications taken by a patient they just met. Some are more open to the idea in certain cases, such as blood pressure medications associated with side effects or adverse outcomes. But if patients cannot identify the high-risk medications they are taking, or if the link between the medication and the chief complaint is weak, it makes the task harder.

  • New Processes ‘Close the Loop’ on Imaging Findings

    University Hospitals Cleveland Medical Center, radiologists report imaging findings through a standardized form integrated in dictation software. This automatically sends an email to a nurse navigator, who documents the findings and coordinates follow-up with patients, primary care providers, and specialists. From July 2021 to May 2022, 1,207 incidental finding reports were submitted, with the vast majority identified on CT scans. Ten new cancers were detected as a result of the program.

  • ED Makes Discharge Safer for Pediatric Patients

    Preventable, serious safety events related to discharge from the ED motivated clinicians at Boston Children’s Hospital to implement a standardized process. Staff follow and review all events locally within the department of emergency medicine, which can include some return visits. The emphasis is on family engagement and multidisciplinary communication.

  • Pediatric Mental Health Crisis Is ECRI’s Top Safety Concern for 2023

    The ED assessment should include appropriate triage: screening for harm of self or others, a thorough assessment, and consideration of social determinants of health.